These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 36206651)

  • 1. The function of myeloid-derived suppressor cells in COVID-19 lymphopenia.
    Li T; Zheng F; Cheng F
    Int Immunopharmacol; 2022 Nov; 112():109277. PubMed ID: 36206651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expansion of myeloid-derived suppressor cells in patients with severe coronavirus disease (COVID-19).
    Agrati C; Sacchi A; Bordoni V; Cimini E; Notari S; Grassi G; Casetti R; Tartaglia E; Lalle E; D'Abramo A; Castilletti C; Marchioni L; Shi Y; Mariano A; Song JW; Zhang JY; Wang FS; Zhang C; Fimia GM; Capobianchi MR; Piacentini M; Antinori A; Nicastri E; Maeurer M; Zumla A; Ippolito G
    Cell Death Differ; 2020 Nov; 27(11):3196-3207. PubMed ID: 32514047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myeloid-derived suppressor cells in COVID-19: A review.
    Perfilyeva YV; Ostapchuk YO; Tleulieva R; Kali A; Abdolla N; Krasnoshtanov VK; Perfilyeva AV; Belyaev NN
    Clin Immunol; 2022 May; 238():109024. PubMed ID: 35489643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional monocytic myeloid-derived suppressor cells increase in blood but not airways and predict COVID-19 severity.
    Falck-Jones S; Vangeti S; Yu M; Falck-Jones R; Cagigi A; Badolati I; Österberg B; Lautenbach MJ; Åhlberg E; Lin A; Lepzien R; Szurgot I; Lenart K; Hellgren F; Maecker H; Sälde J; Albert J; Johansson N; Bell M; Loré K; Färnert A; Smed-Sörensen A
    J Clin Invest; 2021 Mar; 131(6):. PubMed ID: 33492309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunophenotype and function of circulating myeloid derived suppressor cells in COVID-19 patients.
    Kiaee F; Jamaati H; Shahi H; Roofchayee ND; Varahram M; Folkerts G; Garssen J; Adcock IM; Mortaz E
    Sci Rep; 2022 Dec; 12(1):22570. PubMed ID: 36581679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostaglandin D
    Gupta A; Chander Chiang K
    Med Hypotheses; 2020 Oct; 143():110122. PubMed ID: 32759007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low Levels of Granulocytic Myeloid-Derived Suppressor Cells May Be a Good Marker of Survival in the Follow-Up of Patients With Severe COVID-19.
    Jiménez-Cortegana C; Sánchez-Jiménez F; Pérez-Pérez A; Álvarez N; Sousa A; Cantón-Bulnes L; Vilariño-García T; Fuentes S; Martín S; Jiménez M; León-Justel A; de la Cruz-Merino L; Garnacho-Montero J; Sánchez-Margalet V
    Front Immunol; 2021; 12():801410. PubMed ID: 35154077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myeloid-Derived Suppressor Cells as a Potential Biomarker and Therapeutic Target in COVID-19.
    Rowlands M; Segal F; Hartl D
    Front Immunol; 2021; 12():697405. PubMed ID: 34220859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of T Regulatory Cells and Myeloid-Derived Suppressor Cells in COVID-19.
    Alsalman A; Al-Mterin MA; Elkord E
    J Immunol Res; 2022; 2022():5545319. PubMed ID: 35497875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation of myeloid-derived suppressor cells with C-reactive protein, ferritin and lactate dehydrogenase levels in patients with severe COVID-19.
    Emsen A; Sumer S; Tulek B; Cizmecioglu H; Vatansev H; Goktepe MH; Kanat F; Koksal Y; Arslan U; Artac H
    Scand J Immunol; 2022 Jan; 95(1):e13108. PubMed ID: 34625989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Study of monocytic myeloid-derived suppressor cells and CD4 lymphopenia in septic shock-induced immunosuppression].
    Waeckel L; Venet F; Gossez M; Monard C; Rimmelé T; Monneret G
    Ann Biol Clin (Paris); 2021 Feb; 79(1):17-27. PubMed ID: 33563585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neutrophilic Myeloid-Derived Suppressor Cells and Severity in SARS-CoV-2 Infection.
    Omar MA; El Hawary R; Eldash A; Sadek KM; Soliman NA; Hanna MOF; Shawky SM
    Lab Med; 2024 Mar; 55(2):153-161. PubMed ID: 37352143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic programs define dysfunctional immune responses in severe COVID-19 patients.
    Thompson EA; Cascino K; Ordonez AA; Zhou W; Vaghasia A; Hamacher-Brady A; Brady NR; Sun IH; Wang R; Rosenberg AZ; Delannoy M; Rothman R; Fenstermacher K; Sauer L; Shaw-Saliba K; Bloch EM; Redd AD; Tobian AAR; Horton M; Smith K; Pekosz A; D'Alessio FR; Yegnasubramanian S; Ji H; Cox AL; Powell JD
    Cell Rep; 2021 Mar; 34(11):108863. PubMed ID: 33691089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myeloid-Derived Suppressor Cells and Clinical Outcomes in Children With COVID-19.
    Bline K; Andrews A; Moore-Clingenpeel M; Mertz S; Ye F; Best V; Sayegh R; Tomatis-Souverbielle C; Quintero AM; Maynard Z; Glowinski R; Mejias A; Ramilo O
    Front Pediatr; 2022; 10():893045. PubMed ID: 35733812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Functional Roles of MDSCs in Severe COVID-19 Pathogenesis.
    Len JS; Koh CWT; Chan KR
    Viruses; 2023 Dec; 16(1):. PubMed ID: 38257728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SARS-CoV-2-Induced ARDS Associates with MDSC Expansion, Lymphocyte Dysfunction, and Arginine Shortage.
    Reizine F; Lesouhaitier M; Gregoire M; Pinceaux K; Gacouin A; Maamar A; Painvin B; Camus C; Le Tulzo Y; Tattevin P; Revest M; Le Bot A; Ballerie A; Cador-Rousseau B; Lederlin M; Lebouvier T; Launey Y; Latour M; Verdy C; Rossille D; Le Gallou S; Dulong J; Moreau C; Bendavid C; Roussel M; Cogne M; Tarte K; Tadié JM
    J Clin Immunol; 2021 Apr; 41(3):515-525. PubMed ID: 33387156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myeloid-Derived Suppressor Cells in COVID-19: The Paradox of Good.
    Grassi G; Notari S; Gili S; Bordoni V; Casetti R; Cimini E; Tartaglia E; Mariotti D; Agrati C; Sacchi A
    Front Immunol; 2022; 13():842949. PubMed ID: 35572540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Value of interleukin-6 and CD4
    Shi X; Qin L; Yang L; Bai W; Jing L; Mei K
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 Oct; 32(10):1165-1170. PubMed ID: 33198856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myeloid-Derived Suppressor Cells in Psoriasis Are an Expanded Population Exhibiting Diverse T-Cell-Suppressor Mechanisms.
    Cao LY; Chung JS; Teshima T; Feigenbaum L; Cruz PD; Jacobe HT; Chong BF; Ariizumi K
    J Invest Dermatol; 2016 Sep; 136(9):1801-1810. PubMed ID: 27236103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of myeloid derived suppressor cells in sepsis.
    Malavika M; Sanju S; Poorna MR; Vishnu Priya V; Sidharthan N; Varma P; Mony U
    Int Immunopharmacol; 2022 Mar; 104():108452. PubMed ID: 34996010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.